Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| 1 |
SPDR MSCI ACWI ex-US ETF
CWI
|
+$691M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$410M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$403M |
| 4 |
Lockheed Martin
LMT
|
+$385M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$311M |
Top Sells
| 1 |
iShares MSCI Pacific ex Japan ETF
EPP
|
+$677M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$504M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$474M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$396M |
Sector Composition
| 1 | Technology | 15.67% |
| 2 | Financials | 12.74% |
| 3 | Healthcare | 11.15% |
| 4 | Consumer Discretionary | 7.86% |
| 5 | Industrials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Natera
NTRA
$23.7B
| $999K | ﹤0.01% |
41,749
-27,224
| -39% | -$651K |
|
|
VTA
3002
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
| $998K | ﹤0.01% |
87,052
-44,027
| -34% | -$505K |
|
|
TSC
3003
DELISTED
TriState Capital Holdings, Inc.
TSC
| $997K | ﹤0.01% |
36,127
+23,904
| +196% | +$660K |
|
3004
Liquidity Services
LQDT
$846M
| $994K | ﹤0.01% |
156,575
-1,985
| -1% | -$12.6K |
|
3005
Arbutus Biopharma
ABUS
$958M
| $987K | ﹤0.01% |
+104,506
| New | +$987K |
|
|
CRR
3006
DELISTED
Carbo Ceramics Inc.
CRR
| $986K | ﹤0.01% |
136,095
-10,310
| -7% | -$74.7K |
|
3007
Fortis
FTS
$24.7B
| $980K | ﹤0.01% |
30,244
+11,487
| +61% | +$372K |
|
3008
BlackRock Core Bond Trust
BHK
$716M
| $978K | ﹤0.01% |
76,500
+473
| +0.6% | +$6.05K |
|
3009
Carnival PLC
CUK
$38.8B
| $975K | ﹤0.01% |
15,440
-555
| -3% | -$35K |
|
3010
Nuveen Municipal High Income Opportunity Fund
NMZ
$1.21B
| $975K | ﹤0.01% |
77,662
-3,836
| -5% | -$48.2K |
|
3011
Sasol
SSL
$4.53B
| $972K | ﹤0.01% |
25,160
+4,104
| +19% | +$159K |
|
|
SRC
3012
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $971K | ﹤0.01% |
24,063
-50,046
| -68% | -$2.02M |
|
|
HPI
3013
John Hancock Preferred Income Fund
HPI
$448M
| $969K | ﹤0.01% |
44,065
-1,140
| -3% | -$25.1K |
|
3014
Costamare
CMRE
$1.46B
| $968K | ﹤0.01% |
149,124
+46,973
| +46% | +$305K |
|
|
SREV
3015
DELISTED
ServiceSource International, Inc.
SREV
| $968K | ﹤0.01% |
339,776
-36,290
| -10% | -$103K |
|
3016
Cameco
CCJ
$34.9B
| $966K | ﹤0.01% |
84,719
-19,540
| -19% | -$223K |
|
3017
United States Brent Oil Fund
BNO
$101M
| $961K | ﹤0.01% |
41,225
+2,459
| +6% | +$57.3K |
|
|
CHMI
3018
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $961K | ﹤0.01% |
53,102
+12,567
| +31% | +$227K |
|
|
DCPH
3019
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $961K | ﹤0.01% |
24,807
-4,259
| -15% | -$165K |
|
3020
SPDR ICE Preferred Securities ETF
PSK
$835M
| $959K | ﹤0.01% |
22,520
+14,402
| +177% | +$613K |
|
3021
SPDR S&P Software & Services ETF
XSW
$502M
| $958K | ﹤0.01% |
10,559
+1,339
| +15% | +$121K |
|
|
BJZ
3022
DELISTED
Blackrock Ca Muni 2018 Term Tr
BJZ
| $956K | ﹤0.01% |
64,096
-14,644
| -19% | -$218K |
|
|
AGR
3023
DELISTED
Avangrid, Inc.
AGR
| $953K | ﹤0.01% |
19,864
-253
| -1% | -$12.1K |
|
3024
Bausch Health
BHC
$2.68B
| $948K | ﹤0.01% |
36,929
+24,949
| +208% | +$640K |
|
3025
Madrigal Pharmaceuticals
MDGL
$9.7B
| $948K | ﹤0.01% |
4,426
-3,302
| -43% | -$707K |
|